mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.09 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.09 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.09 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.09 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.1 |